These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20662002)

  • 21. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
    Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
    Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
    Tang FH; Hsieh TH; Hsu CY; Lin HY; Long CY; Cheng KH; Tsai EM
    Int J Cancer; 2017 Apr; 140(8):1860-1869. PubMed ID: 28032649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
    Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
    J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
    Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
    J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
    Jochum W
    Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.
    Ponnamperuma RM; King KE; Elsir T; Glick AB; Wahl GM; Nister M; Weinberg WC
    J Pathol; 2009 Oct; 219(2):263-74. PubMed ID: 19718706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53.
    Ghaleb A; Yallowitz A; Marchenko N
    Commun Biol; 2019; 2():436. PubMed ID: 31799437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.
    Ghaleb A; Padellan M; Marchenko N
    Breast Cancer Res; 2020 Dec; 22(1):133. PubMed ID: 33267874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allele specific gain-of-function activity of p53 mutants in lung cancer cells.
    Vaughan CA; Frum R; Pearsall I; Singh S; Windle B; Yeudall A; Deb SP; Deb S
    Biochem Biophys Res Commun; 2012 Nov; 428(1):6-10. PubMed ID: 22989750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.
    Schofield HK; Zeller J; Espinoza C; Halbrook CJ; Del Vecchio A; Magnuson B; Fabo T; Cali Daylan AE; Kovalenko I; Lee HJ; Yan W; Feng Y; Karim SA; Kremer DM; Kumar-Sinha C; Lyssiotis CA; Ljungman M; Morton JP; Galbán S; Fearon ER; Pasca di Magliano M
    JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.
    Hernandez I; Maddison LA; Wei Y; DeMayo F; Petras T; Li B; Gingrich JR; Rosen JM; Greenberg NM
    Mol Cancer Res; 2003 Dec; 1(14):1036-47. PubMed ID: 14707287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
    Heinlein C; Krepulat F; Löhler J; Speidel D; Deppert W; Tolstonog GV
    Int J Cancer; 2008 Apr; 122(8):1701-9. PubMed ID: 18092324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
    Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK
    PLoS One; 2013; 8(11):e80885. PubMed ID: 24260500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells.
    Fan HY; Liu Z; Paquet M; Wang J; Lydon JP; DeMayo FJ; Richards JS
    Cancer Res; 2009 Aug; 69(16):6463-72. PubMed ID: 19679546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells.
    Blum JM; Añó L; Li Z; Van Mater D; Bennett BD; Sachdeva M; Lagutina I; Zhang M; Mito JK; Dodd LG; Cardona DM; Dodd RD; Williams N; Ma Y; Lepper C; Linardic CM; Mukherjee S; Grosveld GC; Fan CM; Kirsch DG
    Cell Rep; 2013 Nov; 5(4):933-40. PubMed ID: 24239359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pax3 loss of function delays tumour progression in kRAS-induced zebrafish rhabdomyosarcoma models.
    Kahsay A; Rodriguez-Marquez E; López-Pérez A; Hörnblad A; von Hofsten J
    Sci Rep; 2022 Oct; 12(1):17149. PubMed ID: 36229514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
    Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
    J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS
    Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK
    Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.